Drug
Levoketoconazole
Levoketoconazole is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Phase Distribution
Ph phase_1
2
40%
Ph phase_3
3
60%
Phase Distribution
2
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 3Large-scale testing
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 33 (60.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Open-label Treatment in Cushing's Syndrome
NCT03621280
completedphase_3
A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
NCT03277690
completedphase_3
Treatment for Endogenous Cushing's Syndrome
NCT01838551
completedphase_1
Bioavailability of Levoketoconazole and Ketoconazole Tablets
NCT04212000
completedphase_1
Levoketoconazole Food Effect Study in Healthy Subjects
NCT03768388
Clinical Trials (5)
Showing 5 of 5 trials
NCT03621280Phase 3
Open-label Treatment in Cushing's Syndrome
NCT03277690Phase 3
A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
NCT01838551Phase 3
Treatment for Endogenous Cushing's Syndrome
NCT04212000Phase 1
Bioavailability of Levoketoconazole and Ketoconazole Tablets
NCT03768388Phase 1
Levoketoconazole Food Effect Study in Healthy Subjects
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5